SCHEMBL9059550

SCHEMBL9059550

CSc1ccc(-c2ccccc2)c(N=C(N)N2CCN(C)CC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 3/20 0.39
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
POLB P06746 1/20 0.36
CYP2C9 P11712 2/20 0.36
KDM4E B2RXH2 1/20 0.35
CHRM1 P11229 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
SCN1A P35498 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9060033 0.91 ALDH1A1 (0.40) ALDH1A1HPGDHSD17B10MAPTPTGS1
SCHEMBL9059966 0.86 SIGMAR1 (0.39) PTGS1PTGS2CHRM1GRIN2DGRIN3B
SCHEMBL9059945 0.83 POLB (0.38) ALDH1A1HPGDMAPTPOLBCYP2C9
SCHEMBL9059786 0.82 SIGMAR1 (0.46) MAPTPOLBCYP2C9KDM4ESIGMAR1
SCHEMBL9059686 0.78 KDM4E (0.39) ALDH1A1HSD17B10MAPTPTGS1PTGS2
SCHEMBL9059642 0.77 SIGMAR1 (0.39) PTGS1PTGS2KDM4ECHRM1GRIN2D
SCHEMBL9059169 0.77 POLB (0.39) ALDH1A1POLBKDM4ECHEK1SMN1; SMN2
SCHEMBL9059335 0.76 MET (0.39) ALDH1A1HPGDMAPTPOLBKDM4E
SCHEMBL9059864 0.72 SIGMAR1 (0.40) CYP2C9SIGMAR1CYP2D6CYP2C19
SCHEMBL9059545 0.72 MAPT (0.45) ALDH1A1HPGDHSD17B10MAPTPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
EP-0536151-B1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM BOOTS CO PLC (GB) 1994-09-14 EP disclosed
US-5302720-A Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents THE BOOTS COMPANY (GB) 1994-04-12 US disclosed
EP-0536151-A1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM. BOOTS CO PLC (GB) 1993-04-14 EP disclosed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO disclosed